Skip to main content

Advertisement

SpringerLink
Log in

Return-to-Play in 2017 and the Role of Shared Decision-Making in Patients with Inherited and Acquired Channelopathies and Cardiomyopathies

  • Sports Cardiology (M Emery, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Shared decision-making is based upon a physician-patient encounter in which there is adequate education using aids if needed, a mutual discussion of how to assist the patient in weighing risks and benefits, and a supportive environment that allows the patient to deliberate on the clinical decision and make their own choice. This decision-making paradigm centers on the principles of autonomy and self-determination. Physical activity is a critical part of healthy lifestyle choices that helps lower risk of cardiovascular disease or the progression of it. Exercise is also a significant contributor to quality of life in many patients in additional to the health benefits. In patients with inherited or acquired cardiovascular disease, exercise may increase risk of electrical and hemodynamic instability. There is a paucity of data to guide physicians and committees that create guidelines regarding athletic and fitness participation in these patients, particularly when the patient wants to participate in those activities that are considered moderate-severe in intensity. As a consequence, the principles of shared decision-making are critical for physicians to use to help patients with cardiovascular disease make the best decision regarding fitness participation that will minimize their risk of new disease or progression of their disease and enhance their quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009:CD001431.

  2. Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ. 2010;341:c5146.

    Article  PubMed  Google Scholar 

  3. • Gravel K, Legare F, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals’ perceptions. Implement Sci. 2006;1:16. A systematic review that highlights barriers and facilitators perceived by healthcare professionals to implementing shared decision-making in clinical practice.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013:CD004816.

  5. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long-QT syndrome. International long-QT syndrome registry research group. N Engl J Med. 1998;339:960–5.

    Article  CAS  PubMed  Google Scholar 

  6. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med. 2003;348:1866–74.

    Article  PubMed  Google Scholar 

  7. Mitchell JH, Haskell W, Snell P, Van Camp SP. Task Force 8: classification of sports. J Am Coll Cardiol. 2005;45:1364–7.

    Article  PubMed  Google Scholar 

  8. Villain E, Denjoy I, Lupoglazoff JM, et al. Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. Eur Heart J. 2004;25:1405–11.

    Article  CAS  PubMed  Google Scholar 

  9. Liu JF, Jons C, Moss AJ, et al. Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome. J Am Coll Cardiol. 2011;57:941–50.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Johnson JN, Ackerman MJ. Competitive sports participation in athletes with congenital long QT syndrome. JAMA. 2012;308:764–5.

    Article  CAS  PubMed  Google Scholar 

  11. Aziz PF, Sweeten T, Vogel RL, et al. Sports participation in genotype positive children with long QT syndrome. JACC Clin Electrophysiol. 2015;1:62–70.

    Article  PubMed  PubMed Central  Google Scholar 

  12. •• Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac Channelopathies: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66:24–8. The revised guideline statement for patients with cardiovascular abnormalities includes current recommendations for management with an emphasis to return to fitness and participation when adequate safety measures are in place.

    Article  Google Scholar 

  13. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e273–80.

    Article  PubMed  Google Scholar 

  14. Reineck E, Rolston B, Bragg-Gresham J, Salberg L, Baty L, Kumar S, et al. Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. Am J Cardiol. 2013;111:1034–9.

    Article  PubMed  Google Scholar 

  15. Fletcher GF, Balady G, Blair SN, Blumenthal J, Caspersen C, Chaitman B, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans: a statement for health professionals by the committee on exercise and cardiac rehabilitation of the council on clinical cardiology. American Heart Association Circulation. 1996;94:857e862.

    Google Scholar 

  16. Finocchiaro G, Papadakis M, Dhutia H, et al. Circumstances of sudden death in hypertrophic cardiomyopathy: data from a large pathology registry. Eur Heart J. 2016;37:1226.

    Google Scholar 

  17. Lifestyle and Exercise in Hypertrophic Cardiomyopathy "LIVE-HCM" ClinicalTrials.gov Identifier: NCT02549664.

  18. • Shiroma EJ, Lee IM. Physical activity and cardiovascular health: lessons learned from epidemiological studies across age, gender, and race/ethnicity. Circulation. 2010;122:743–52. Multiple epidemiological studies have highlighted the benefit of activity as a healthy lifestyle choice. The benefits are observed in healthy people, those with risk factors for cardiovascular disease, and those with known cardiac disease.

    Article  PubMed  Google Scholar 

  19. Wannamethee SG, Shaper AG, Walker M. Physical activity and mortality in older men with diagnosed coronary heart disease. Circulation. 2000;102:1358–63.

    Article  CAS  PubMed  Google Scholar 

  20. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1997 exercise testing guidelines). Circulation. 2002;106:1883–92.

    Article  PubMed  Google Scholar 

  21. Stoylen A, Conraads V, Halle M, Linke A, Prescott E, Ellingsen O. Controlled study of myocardial recovery after interval training in heart failure: SMARTEX-HF--rationale and design. Eur J Prev Cardiol. 2012;19:813–21.

    Article  PubMed  Google Scholar 

  22. Arena R, Myers J, Forman DE, Lavie CJ, Guazzi M. Should high-intensity-aerobic interval training become the clinical standard in heart failure? Heart Fail Rev. 2013;18:95–105.

    Article  PubMed  Google Scholar 

  23. Keteyian SJ, Patel M, Kraus WE, et al. Variables measured during cardiopulmonary exercise testing as predictors of mortality in chronic systolic heart failure. J Am Coll Cardiol. 2016;67:780–9.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Intermounetain Medical Center, Eccles Outpatient Care Center, Intermountain Medical Center Heart Institute, 5169 Cottonwood St, Suite 510, Murray, UT, 84107, USA

    Kia Afshar MD & T. Jared Bunch MD

  2. Department of Internal Medicine, Stanford University, Palo Alto, CA, USA

    T. Jared Bunch MD

Authors
  1. Kia Afshar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Jared Bunch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Jared Bunch MD.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Sports Cardiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afshar, K., Bunch, T.J. Return-to-Play in 2017 and the Role of Shared Decision-Making in Patients with Inherited and Acquired Channelopathies and Cardiomyopathies. Curr Treat Options Cardio Med 19, 75 (2017). https://doi.org/10.1007/s11936-017-0574-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11936-017-0574-y

Keywords

Search

Navigation